News – Page 736 – Endpoints News

Three-day FDA adcomm to feature unprecedented review of Merck, Roche and BMS accelerated approvals

5 years ago

Alex Gorsky earned a whopping $29.6M in 2020 as drugmaker pivoted around Covid-19 vaccine R&D

5 years ago

Recall report: BRP Pharma pulls 47 bottles of generic diuretic spironolactone after mixing different strength pills

5 years ago

FDA delays Kadmon’s priority review as apparent clampdown continues

5 years ago

In race for in vivo sickle cell cure, Intellia unveils (very) early proof-of-concept

5 years ago

Covid-19 roundup: Pfizer/BioNTech release real-world evidence of vaccine efficacy; EMA gives J&J shot thumbs up

5 years ago

GlaxoSmithKline, Vir gear up for EUA, citing early PhIII Covid-19 win with 'best-in-class' antibody contender

5 years ago

In the latest twist to IL-6 roller coaster, Roche's Actemra fails PhIII Covid-19 Veklury combo trial

5 years ago

Aveo Oncology gets the long-awaited greenlight to market tivozanib — 9 years after filing its first NDA

5 years ago

Synthetic DNA player Touchlight scores $60M round to more than triple manufacturing capacity as mRNA gets hot

5 years ago

Janet Woodcock and Francis Collins dish on lessons learned from the pandemic

5 years ago

Arctic Vision collects $100M to bring US eye disease candidates overseas

5 years ago

Grifols snags the rest of GigaGen in $80M acquisition; Vertex moves cutting-edge diabetes treatment into the clinic

5 years ago

Bluebird execs exhale after ruling sickle cell therapy 'very unlikely' to have caused AML event. How will FDA react?

5 years ago

CFO departs Intercept as trickle becomes mass exodus from NASH biotech

5 years ago

Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up

5 years ago

FDA calls out Kardashian drug promo video for false claims

5 years ago

Covid-19 roundup: US lands another 100M-dose contract from J&J to back Biden's pledge; Pfizer and BioNTech could ...

5 years ago

With profits lagging, Emma Walmsley, Big Pharma's only woman CEO, may once again be its lowest paid

5 years ago

Another SPAC is gearing up to go public, this time coming from Oleg Nodelman's EcoR1 Capital

5 years ago

Innovation in the clinic is picking up steam. How adaptive designs could pave the road to personalized medicine

5 years ago

Eli Lilly tops up positive PhIII data for its Covid-19 antibody combo at ‘the optimal dose’

5 years ago

AgomAb Therapeutics looks to take its 'true MET agonist' for broad use into the clinic with $74M round

5 years ago

Eli Lilly promotes Edgardo Hernandez to head its manufacturing operations as 19-year vet O'Neill hits the exit

5 years ago

First page Previous page 733 734 735736737 738 739 Next page Last page